Clinical Trials Logo
  1. Home
  2. Itching
  3. NCT05811039

Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal — Remo_Itch  

Itching Clinical Trial

Official title:
Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal; an Open, Single-arm, Non-randomised, Multicentre Clinical Study

Clinical Trial Summary

Open, single-arm, non-randomized study to demonstrate the efficacy of Remo-Wax® Oil (abbreviated RWO) in the treatment of isolated itching of the external ear canal and to demonstrate the safety of the product.

Clinical Trial Description

The study includes a 4-week treatment period with RWO. The first administrations are performed at the study site (Screening/Day 1). Thereafter, the doses are self-administered by the subjects once a day for 2 weeks (Days 2-14) and subsequently, RWO is self-administered once a week for two weeks, i.e. on Days 21 and 28. The subjects may take additional doses as needed at any time point during the treatment period. Final assessments will be performed at the End-of-Study Visit 1-3 days after the last RWO administration. Itching of the ear canals will be assessed with questionnaires at the Screening and End-of-Study Visits. Irritation will be assessed by the ENT (ear-nose-throat) examination at the Screening and End-of-Study Visits. Satisfaction with the treatment procedure will be assessed with a questionnaire at the End-of-Study Visit. The subjects are keeping a study diary to document RWO administrations (as scheduled and potential additional doses), potential deviations from study-related instructions, AEs and device deficiencies (DD). ENT examination including otomicroscopy will be performed at Screening and End-of-Study Visits. AEs and DDs will be recorded throughout the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05811039
Study type Interventional
Source Orion Corporation, Orion Pharma
Contact
Status Completed
Phase N/A
Start date May 17, 2023
Completion date October 5, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02951806 - Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section N/A
Completed NCT00782054 - Evaluation of Post Burn Rehabilitation Population for Itch Control Phase 4
Not yet recruiting NCT01702103 - Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays Phase 3
Not yet recruiting NCT01693198 - Cyanobacteria Allergy in Lake Kineret N/A
Completed NCT00058890 - Gabapentin to Treat Itch in Patients With Liver Disease Phase 3
Recruiting NCT06323304 - Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis N/A
Completed NCT00137202 - Post Burn Pruritus Study in Patients Undergoing Wound Healing N/A
Recruiting NCT04962152 - Naldebain and Video-assisted Thoracoscopic Surgery Phase 4
Completed NCT05766930 - The Novel Electrolyzed Water Spray Treatment the Genital Itching N/A
Completed NCT01795079 - Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury N/A
Completed NCT05367414 - Aromatherapy Massage for Itching Management in Liver Diseases N/A
Recruiting NCT06104540 - Comparison of the Effects of Liquid Vaseline and Olive Oil on Itching and Scarring in Scald Burns N/A
Completed NCT03497130 - The Role of Skin Care Regimen in Skin Health N/A